Next year will start testing the world's first inhaler containing active substances of marijuana. Developer of pharmaceuticals was the company Teva. Along with Syqe Medical, she signed a contract on the commercial use of the inhaler in one of hospitals of Israel. Teva will develop the inhaler, Syqe Medical, cartridges to the device.
The tool will be used during the year in hospital Rambam. At the moment some countries have moved away from full prohibition of marijuana and allow the use of the drug for medical purposes, for example for the treatment of pain in cancer.
The difficulty of assign marijuana as a medical remedy consists in the impossibility of determining accurate dosing in cases when the patient inhales the smoke of the plant. The inhaler addresses this issue, allowing you to apply the drug directly to the hospital.